Guofeng Ji
Impact in
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 7
-
- Nanoplatforms for cancer theranostics 7
- Co-authors
- Xinghui Si (13 shared papers)Wantong Song (11 shared papers)Zhaohui Tang (7 shared papers)Sheng Ma (7 shared papers)Haochen Yao (5 shared papers)Xuedong Fang (4 shared papers)Chong Ma (4 shared papers)Jiayu Zhao (4 shared papers)
- Journals
- Medicine (2 papers)Frontiers in Immunology (2 papers)Advanced Science (2 papers)Nano Letters (2 papers)Proceedings of the Institution of Mechanical Engineers Part A Journal of Power and Energy (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Guofeng Ji
21 papers receiving 369 citations
Peers
Comparison fields: 5 of 66
- Immunology 135
- Biomaterials 79
- Oncology 145
- Biotechnology 41
- Biomedical Engineering 160
Countries citing papers authored by Guofeng Ji
This map shows the geographic impact of Guofeng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Ji more than expected).
Fields of papers citing papers by Guofeng Ji
This network shows the impact of papers produced by Guofeng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Ji. The network helps show where Guofeng Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Guofeng Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2020 | 53 | |
| 3 | 2021 | 36 | |
| 4 | 2021 | 35 | |
| 5 | 2022 | 24 | |
| 6 | 2020 | 20 | |
| 7 | 2020 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2024 | 10 | |
| 11 | 2021 | 8 | |
| 12 | 2024 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2024 | 6 | |
| 15 | [Comparative study of three-dimensional and two-dimensional laparoscopic-assisted D2 radical gastrectomy in short-term efficacy]. | 2016 | 6 |
| 16 | 2024 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2020 | 2 |
About Guofeng Ji
Guofeng Ji is a scholar working on Oncology, Biomedical Engineering, Immunology, Surgery and Biomaterials, having authored 23 papers that have together received 371 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (5 papers), Heat Transfer Mechanisms (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Turbomachinery Performance and Optimization (4 papers), Intraperitoneal and Appendiceal Malignancies (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Immunology (135 citations), Biomaterials (79 citations), Oncology (145 citations), Biotechnology (41 citations) and Biomedical Engineering (160 citations). Guofeng Ji has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xinghui Si, Wantong Song, Zhaohui Tang, Sheng Ma, Haochen Yao, Xuedong Fang, Chong Ma, Jiayu Zhao, Yudi Xu and Xuesi Chen. Their work appears in journals such as Medicine, Frontiers in Immunology, Advanced Science, Nano Letters and Proceedings of the Institution of Mechanical Engineers Part A Journal of Power and Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.